Physician profile
Omar Sheikh
NPI 1083110464
$4,627.13
in general payments reported to CMS, 2019-2025
12 companies · $520 in 2025
The $520 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $80.87 · 2023: $384 · 2024: $3,643 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,698 · Travel and Lodging: $1,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,697.65 |
| Travel and Lodging | $1,848.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,697.65 | 2024-2025 | Avvigo Guidance System, Ekosonic |
| Abbott Laboratories | $1,354.22 | 2024-2025 | Perclose Proglide, Esprit, Xience Sierra |
| Abiomed | $845.26 | 2023-2024 | Impella |
| Stryker Corporation | $185.04 | 2025 | Limflow System |
| Medtronic, INC. | $130.00 | 2024 | Corevalve Evolut R |
| Biotronik INC. | $80.87 | 2022 | |
| Edwards Lifesciences Corporation | $79.95 | 2024 | |
| Abbvie INC. | $79.10 | 2025 | |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Ethicon INC. | $33.92 | 2025 | Monarch Platform |
| Esperion Therapeutics, INC. | $21.12 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Sheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.